Inflow secures £9 million Series A investment led by Octopus Ventures

NEW YORK, JANUARY 11TH 2023: Inflow, the science-based app that helps members better manage ADHD through Cognitive Behavioral Therapy (CBT) based support, has raised a $11M Series A round led by Octopus Ventures, the multi-stage European VC firm.

Returning participants in the round include the London-based early stage venture firm Hoxton Ventures and Route66 Ventures, which support founders that use tech for positive change. Will Gibbs, Healthtech Partner at Octopus Ventures, will join the Inflow board.

Founded in 2020 by Levi EpsteinSeb Isaacs and Dr George Sachs (a clinical psychologist with over 10 years of experience treating ADHD), Inflow helps people with ADHD to better understand and manage their symptom. The app has been built by a team of leading clinicians and coaches, with a large portion of the team being neurodiverse, including Co-founder Dr George Sachs. 

Inflow was born out of frustration with the long waiting times, difficult bureaucratic processes, and prohibitive costs. By using CBT-based coping strategies, considered part of the gold standard of ADHD care, Inflow is an accessible and affordable approach. It enables its members to develop self-regulation techniques that can be embedded within their everyday routines, help them overcome any unhelpful patterns of thinking, learn useful habits and skills, and take exercises and challenges. 

Inflow also provides group and community-based support where members can attend live events, hosted by qualified clinicians and in-app coaches, including co-founder Dr George Sachs and the company’s clinical advisors, Dr Laura Knouse, Associate Professor of Psychology at the University of Richmond, and Dr Lidia Zylowska, Associate Professor at the University of Minnesota, who both specialize in adult ADHD. These sessions provide individuals with the support and accountability that can help them to stay on track.

Seb Isaacs, Co-founder of Inflow, comments:

“Diagnosing and treating ADHD can be a long and costly process, and living with the symptoms can be extremely challenging. We want to help our members make significant improvements to their quality of life by giving them the tools to better understand themselves, and implement coping strategies that actually work.”

Dr George Sachs, Co-founder of Inflow, added:

“To ensure the usability and feasibility of the Inflow app, since launching, we have preliminary results through open study testing that members have experienced a decrease in ADHD symptoms and impairment by following Inflow’s approach. It’s encouraging and edifying to see how providing these techniques to those with ADHD, directly and easily through our app, is making a difference to their lives.”

Will Gibbs, Partner at Octopus Ventures, adds:

“People with ADHD represent around 10% of the global population and Inflow is offering a new way to help them access the most effective support. The team has built a community of users who are already seeing a real impact on their lives and Inflow’s B2C “global from day 1” approach means there is an opportunity to quickly reach meaningful scale. We believe Inflow can become a world-changing business making a huge impact on people’s lives, and not just those with ADHD but in a range of neurological areas in the future.”

Inflow has raised over $14M to-date and will use the new funding for product development and to further expand its team.

About Inflow

New York and London-based Inflow is an app that helps people with ADHD to better understand and manage their symptom through Cognitive Behavioral Therapy (CBT) based support. Founded in 2020 by Levi Epstein, Seb Isaacs, and Dr George Sachs, a clinical psychologist with over 10 years of experience treating ADHD, Inflow has raised over $14M to-date from Octopus Ventures, Hoxton Ventures, Route66 Ventures, and angel investors, Yusuf Sherwani, Maroof Ahmed, and Sarim Siddiquiare (co-founders of Quit Genius) and Joshua Browder (CEO of DoNotPay).

About Octopus Ventures

For the people and ideas that will change the world, because we believe you can build a better tomorrow by investing in it. We can back you at every stage of your journey, from ideas on a page through to IPO. Each year we deploy more than £200 million across five areas where we see maximum potential for impact: health, fintech, deep tech, consumer and B2B software. With many years of experience and expertise investing in each of these areas, our team can help our portfolio companies scale at speed. For us, investment is about more than money. Being truly invested is about giving time, energy and focus; working with founders to give them the best chance of success. It means a shared commitment to solving the big problems that matter. We’ve backed the likes of ManyPets, Cazoo, Depop, Elvie and WaveOptics, while others have gone on to join forces with the world’s largest businesses. We are based in London and New York with a network of partners across the U.S and Asia.

Wishma

Related post

This will close in 25 seconds